HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugs
Background Epigenetics research is progressing in basic, pre-clinical and clinical studies
using various model systems. Hence, updating the knowledge and integration of biological …
using various model systems. Hence, updating the knowledge and integration of biological …
H2AFZ: A Novel Prognostic Marker in Canine Melanoma and a Predictive Marker for Resistance to CDK4/6 Inhibitor Treatment
L Bongiovanni, A Andriessen, S Silvestri… - Frontiers in Veterinary …, 2021 - frontiersin.org
Uncontrolled proliferation is a key feature of tumor progression and malignancy. This
suggests that cell-cycle related factors could be exploited as cancer biomarkers and that …
suggests that cell-cycle related factors could be exploited as cancer biomarkers and that …
The Function of the Tumor Suppressor CYLD in Endothelial-Associated and Epigenetic Processes in Malignant Melanoma
M Schott - 2022 - search.proquest.com
Die Deubiquitinase CYLD beeinflusst ein weites Spektrum an physiologischen Prozessen,
welche von der Immunreaktion und Entzündung bis hin zur Zell-Zyklus-Progression oder …
welche von der Immunreaktion und Entzündung bis hin zur Zell-Zyklus-Progression oder …
Welcome to the Fourth Volume of Melanoma Management and a Look Back at 2016
S Dennis-Beron - Melanoma Management, 2017 - Taylor & Francis
We are delighted to welcome all our readers to the fourth volume of Melanoma
Management. The year 2016 was a ground breaking year in melanoma research and …
Management. The year 2016 was a ground breaking year in melanoma research and …
[引用][C] Die Funktion des Tumorsuppressors CYLD in endothelial-assoziierten und epigenetischen Prozessen im malignen Melanom
M Schott - 2022 - Dissertation, Erlangen, Friedrich …